Valuation : Balchem Corporation

Market Cap 5.24B 4.52B 4.28B 3.88B 7.27B 501B 7.31B 50.78B 19.53B 255B 19.68B 19.25B 805B P/E 2026 *
30.4x
P/E 2027 * 29.2x
Enterprise Value 5.28B 4.55B 4.3B 3.9B 7.32B 504B 7.36B 51.12B 19.66B 256B 19.81B 19.38B 810B EV / Sales 2026 *
4.66x
EV / Sales 2027 * 4.35x
Free-Float
99.53%
Yield 2026 *
0.71%
Yield 2027 * 0.79%
1 day-1.37%
1 week-4.21%
Current month-6.54%
1 month-8.55%
3 months-0.39%
6 months-3.51%
Current year+7.19%
1 week 164.16
Extreme 164.16
171.27
1 month 164.16
Extreme 164.16
182.99
Current year 152.58
Extreme 152.58
183.9
1 year 139.17
Extreme 139.17
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 65.37
Extreme 65.37
186.03
Manager TitleAgeSince
Chief Executive Officer 61 27/04/2015
Director of Finance/CFO 49 03/02/2019
Chief Tech/Sci/R&D Officer 56 30/09/2025
Director TitleAgeSince
Director/Board Member 63 15/09/2010
Chairman 61 31/12/2016
Director/Board Member 59 14/09/2015
Date Insider Type Main position Quantity % Market Cap. Importance
01/04/26 Other

Controller/Auditor

8,646 0.0270%
11/02/26 Free

Director

870 0.0027%
11/02/26 Free

Director

870 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
-1.37%-4.21%+5.15%+25.14% 5.24B
+1.69%-1.11%+1.31%+51.65% 77.42B
-0.16%-3.62%+0.03%-22.14% 36.38B
+0.16%-2.65%-7.24%+11.41% 35.8B
-0.22%-2.66%-11.43%+9.50% 25.11B
+0.13%+0.89%+32.34%+24.96% 22.82B
-3.60%-8.57%+66.50%+20.17% 19.96B
-0.26%-3.50%-45.23%-43.70% 17.15B
-3.43%-6.94%+54.67%-36.25% 13.87B
+0.28%-6.72%-7.32%+56.34% 13.86B
Average -0.68%-3.97%+8.88%+9.71% 26.76B
Weighted average by Cap. +0.00%-3.04%+5.71%+16.71%

Financials

2026 *2027 *
Net sales 1.13B 975M 923M 837M 1.57B 108B 1.58B 10.96B 4.22B 55B 4.25B 4.16B 174B 1.2B 1.03B 976M 884M 1.66B 114B 1.67B 11.59B 4.46B 58.12B 4.49B 4.39B 184B
Net income 175M 151M 143M 129M 243M 16.7B 244M 1.69B 651M 8.5B 657M 642M 26.85B 182M 157M 149M 135M 253M 17.41B 254M 1.77B 679M 8.86B 684M 669M 27.99B
Net Debt 35.51M 30.6M 28.97M 26.26M 49.26M 3.39B 49.51M 344M 132M 1.73B 133M 130M 5.45B -39.68M -34.19M -32.37M -29.34M -55.04M -3.79B -55.32M -384M -148M -1.93B -149M -146M -6.09B
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,379
Date Price Change Volume
11/09/26 US$164.39 -1.37% 250,642
10/09/26 US$166.67 -0.99% 127,765
09/09/26 US$168.34 -1.30% 121,657
08/09/26 US$170.56 -0.61% 138,261
04/09/26 US$171.61 -0.08% 89,947
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
164.39USD
Average target price
209.25USD
Spread / Average Target
+27.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BCPC Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!